WallStSmart
ZYBT

Zhengye Biotechnology Holding Limited Ordinary Shares

NASDAQ: ZYBT · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$0.92
+5.75% today

Updated 2026-04-30

Market cap
$43.72M
P/E ratio
P/S ratio
0.28x
EPS (TTM)
$-0.06
Dividend yield
52W range
$1 – $14
Volume
0.3M

WallStSmart proprietary scores

26
out of 100
Grade: F
Strong Sell
Investment rating
2.0
Growth
F
5.0
Quality
C+
2.0
Profitability
F
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$—
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
+ Free cash flow $13.27M — positive
Risks
- Thin margins at -12.60%
- Revenue declining -34.40% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$260.27M$211.65M$186.36M$186.36M$153.74M
Net income$46.73M$31.46M$11.31M$11.31M$11.31M
EPS$-0.06
Free cash flow$-9.99M$36.58M$13.27M$13.27M$13.27M
Profit margin17.96%14.86%6.07%6.07%-12.60%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
ZYBT$43.72M262.02.05.05.0Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Zhengye Biotechnology Holding Limited Ordinary Shares trades at $0.92. Our Smart Value Score of 26/100 indicates the stock is weak. TTM revenue stands at $153.74M. with profit margins at -12.60%.

Frequently asked questions

What is Zhengye Biotechnology Holding Limited Ordinary Shares's stock price?
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) trades at $0.92.
Is Zhengye Biotechnology Holding Limited Ordinary Shares overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell).
What is the price target of Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT)?
The analyst target price is $—, representing NaN% downside from the current price of $0.92.
What is Zhengye Biotechnology Holding Limited Ordinary Shares's revenue?
TTM revenue is $153.74M.

Company info

SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio0.28x
ROE-6.38%
Beta
50D MA$0.89
200D MA$3.06
Shares out0.05B
Float0.00B
Short ratio
Avg volume0.3M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years